Search Results 301-310 of 23004 for Phase

  1. Phase 2 Study Of Inhaled SNG001 In Mechanically Ventilated Patients With Respiratory Viral Infection - Mayo Clinic

    The goal of this Phase 2 study is to assess about the safety, antiviral biomarker responses and efficacy of SNG001 when given to patients requiring invasive ...

  2. Phase 2 Study of TAK-341 for Multiple System Atrophy - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  3. A Phase 3 Study to Examine the Effectiveness, Safety and Tolerability of APL-130277 for the Acute Treatment of Motor Fluctuation Episodes in Patients with Parkinson's Disease - Mayo Clinic

    A Phase 3 Study to Examine the Effectiveness, Safety and Tolerability of APL-130277 for the Acute Treatment of Motor Fluctuation Episodes in Patients with ...

  4. Dynamic Assessment of Vascular Run-Offs using a Multi-phase Protocol and Reduced Contrast Bolus - Mayo Clinic

    The purposes for this study are to determine the ability of volumetric dynamic 4D CTA compared to replace current single-phase CTA and eliminate venous ...

  5. S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer - Mayo Clinic

    The purpose of this study is to compare overall survival in newly diagnosed metastatic prostate cancer patients randomly assigned to androgen deprivation ...

  6. A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD - Mayo Clinic

    The purpose of the study is to evaluate the safety and efficacy of GLASSIA as an add-on biopharmacotherapy to standard-of-care steroid treatment as the first- ...

  7. A Study Of VAsotoxicity Surveillance Using EndoPAT: The VASA Pilot Study - Mayo Clinic

    There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should ...

  8. Phase 2 Trial of Blinatumomab in Philadelphia Positive/BCR-ABL Positive Acute Lymphoblastic Leukemia - Mayo Clinic

    Phase 2 Trial of Blinatumomab in Philadelphia Positive/BCR-ABL Positive Acute Lymphoblastic Leukemia · Overview · Participation eligibility · Participating Mayo ...

  9. Expediting Patient Identification of LGI1-IgG Autoimmune Encephalitis for Enrollment into Phase 2 Study - Mayo Clinic

    The purpose of this study is to expedite patient identification of LGI1-IgG autoimmune encephalitis patients for enrollment in the UCB sponsored phase 2 study ...

  10. Financial Toxicity Among Patients in Phase I Clinical Trials

    ... phase I clinical trials. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...